Summary of Significant Accounting Policies (Details)			3 Months Ended		6 Months Ended		12 Months Ended
	Jan. 01, 2016	Dec. 31, 2015 USD ($)	Jun. 30, 2016 USD ($)	Jun. 30, 2015 USD ($)	Jun. 30, 2016 USD ($) Segment	Jun. 30, 2015 USD ($)	Dec. 31, 2015 USD ($)
Summary of Significant Accounting Policies [Line Items]
Provision for inventory obsolescence					$ 200,000	$ 600,000
Pre-launch Inventory		$ 0	$ 0		0		$ 0
Goodwill, in-process research and development and other intangible assets acquired		2,200,000,000	2,100,000,000		2,100,000,000		2,200,000,000
Amortization expense			15,778,000	$ 3,236,000	29,221,000	5,901,000
In-process research and development		792,275,000	606,035,000		606,035,000		792,275,000
Income tax (provision) benefit			(15,868,000)	(251,000)	4,638,000	(5,760,000)
Depreciation expense					17,600,000	1,800,000
Revenue from transfer of intellectual property and other			68,281,000	17,673,000	86,898,000	30,202,000
Total deferred revenue		232,900,000	198,500,000		198,500,000		232,900,000
Accounts receivable, gross		219,043,000	262,145,000		262,145,000		219,043,000
Allowance for doubtful accounts receivable		25,168,000	48,773,000		48,773,000		25,168,000
Provision for bad debts					40,500,000	600,000
Equity-based compensation expense					$ 26,105,000	$ 14,090,000
Number of reportable segments | Segment					2
Minimum
Summary of Significant Accounting Policies [Line Items]
Intangible assets, estimated useful lives					3 years
Maximum
Summary of Significant Accounting Policies [Line Items]
Intangible assets, estimated useful lives					20 years
Government Contracts Concentration Risk
Summary of Significant Accounting Policies [Line Items]
Accounts receivable, gross		$ 26,100,000	30,400,000		$ 30,400,000		$ 26,100,000
Government Contracts Concentration Risk | Sales Revenue, Net
Summary of Significant Accounting Policies [Line Items]
Concentration percentage					10.00%	4.00%
Software
Summary of Significant Accounting Policies [Line Items]
Useful life					3 years
Machinery, Medical and Other Equipment | Minimum
Summary of Significant Accounting Policies [Line Items]
Useful life					5 years
Machinery, Medical and Other Equipment | Maximum
Summary of Significant Accounting Policies [Line Items]
Useful life					8 years
Furniture and Fixtures | Minimum
Summary of Significant Accounting Policies [Line Items]
Useful life					5 years
Furniture and Fixtures | Maximum
Summary of Significant Accounting Policies [Line Items]
Useful life					10 years
Buildings and Improvements | Minimum
Summary of Significant Accounting Policies [Line Items]
Useful life					10 years
Buildings and Improvements | Maximum
Summary of Significant Accounting Policies [Line Items]
Useful life					40 years
Automobiles and Aircraft | Minimum
Summary of Significant Accounting Policies [Line Items]
Useful life					3 years
Automobiles and Aircraft | Maximum
Summary of Significant Accounting Policies [Line Items]
Useful life					15 years
Collaborative Arrangement, Product | Pfizer
Summary of Significant Accounting Policies [Line Items]
Revenue from transfer of intellectual property and other			17,700,000	$ 17,700,000	$ 35,300,000	$ 30,200,000
Total deferred revenue			$ 194,200,000		$ 194,200,000
Self-Pay | Accounts Receivable
Summary of Significant Accounting Policies [Line Items]
Concentration percentage					6.60%		7.50%
Internal Revenue Service (IRS)
Summary of Significant Accounting Policies [Line Items]
Corporate income tax rate			35.00%	35.00%	35.00%	35.00%
Israel Tax Authority
Summary of Significant Accounting Policies [Line Items]
Corporate income tax rate	25.00%	26.50%			25.00%
Scenario, Adjustment
Summary of Significant Accounting Policies [Line Items]
In-process research and development			$ (187,600,000)		$ (187,600,000)
Intangible Assets, Net | Scenario, Adjustment
Summary of Significant Accounting Policies [Line Items]
In-process research and development			187,600,000		$ 187,600,000
Change in Income Tax Accounting Method
Summary of Significant Accounting Policies [Line Items]
Income tax (provision) benefit			51,200,000
Change in Income Tax Accounting Method | Other Current Assets and Prepaid Expenses
Summary of Significant Accounting Policies [Line Items]
Income tax (provision) benefit			39,400,000
Change in Income Tax Accounting Method | Deferred Tax Liabilities
Summary of Significant Accounting Policies [Line Items]
Income tax (provision) benefit			$ 11,800,000
In-process Research and Development
Summary of Significant Accounting Policies [Line Items]
Intangible assets, estimated useful lives					12 years